|
Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
abstract:
Review paper
Eyelid tumors
Anna Rzeszotarska
1, 2
,
Monika Czajkowska
1
,
Julia Lewandowska
1
,
Wojciech Adamski
1, 2
KLINIKA OCZNA 2025, 127, 3
Online publish date: 2025/09/12
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Introduction
Analysis of cases of eyelid tumors scheduled for surgical excision. Material and methods This retrospective study included 91 patients (61 women and 30 men) aged 48 to 90 years. All patients underwent surgical excision or biopsy of eyelid lesions between September 2022 and February 2024. Malignant lesions were suspected in all cases during preoperative evaluation. Following surgery, all specimens underwent histopathological examination. Results Basal cell carcinoma, the most common lesion in the study group, was diagnosed in 75 patients. Benign or malignant changes confirmed in the remaining cases included: seborrheic keratosis, actinic keratosis, squamous cell carcinoma, cutaneous melanoma, Merkel cell carcinoma, papillomatous squamous cell carcinoma, molluscum contagiosum, and melanocytic nevus. Histopathological examination revealed no pathological changes in 3 patients. Conclusions Eyelid tumors, particularly those with macroscopic features suggestive of malignancy, require complete surgical excision and thorough histopathological evaluation to ensure accurate diagnosis and enable appropriate subsequent treatment. keywords:
eyelid lesions, tumors, ocular oncology |
POLSKI
